Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status

Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.59.9191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Breast Cancer Incidence in Young Women by Estrogen Receptor Status and Race.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Coexpression of NOS2 and COX2 Accelerates Tumor Growth and Reduces Survival in Estrogen Receptor-Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Transcriptome‐wide Association Study of Breast Cancer Risk by Estrogen‐receptor Status

Genetic Epidemiology
EpidemiologyGenetics
2020English

Folate Intake and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Oestrogen Receptor Status and Survival in Women With BRCA2-associated Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

An Approximate Expression for the Proportion Explained by Mediation in Survival Analysis

Epidemiology
Epidemiology
2020English

Therapeutically Targeting Tumor Microenvironment–mediated Drug Resistance in Estrogen Receptor–positive Breast Cancer

Journal of Experimental Medicine
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy